Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
GXO Logistics heads into its November 3 earnings with a striking split: Goldman Sachs upgraded the stock to Buy this week, yet short sellers have spent the past month quietly rebuilding positions.
Short interest has climbed sharply, up 14% over the past week and nearly 11% over the past month, bringing it to 6.5% of the free float. That is a meaningful level for a mid-cap logistics name, and the direction of travel is clear. The borrow market tells a different story, though. Availability is extremely loose at 490%, meaning roughly five shares remain available to lend for every one already borrowed. Cost to borrow has edged down slightly and is below 0.5%, which suggests the rebuilding of short positions is not squeezing supply and reflects deliberate positioning rather than a forced scramble. The ORTEX short score has risen to 53.1 from 49 at the start of October, a modest but consistent move higher over two weeks.
Options traders have become noticeably more cautious. The put/call ratio is running at 0.69, well above its 20-day average of 0.49 and about one standard deviation above that mean. The ratio has been elevated for the better part of two weeks, having jumped from near-record lows around 0.14 in late September. That shift from extreme call dominance to a more hedged posture is the sharpest sentiment reversal in the options book in several months.
Goldman Sachs is the headline on the Street this week. Analyst Patrick Creuset upgraded GXO to Buy today, maintaining the existing $61 price target, a 31% premium to the current $46.50 close. The broader analyst community is firmly bullish: 13 buy ratings, no holds. However, targets have been under pressure since the August earnings print, which sent the stock down around 6% on the day and a further 8% over the following week. UBS, Susquehanna and Truist all trimmed targets materially in August and July, with UBS cutting from $74 to $64. The consensus target now averages around $64, which implies meaningful upside but follows a sustained period of negative revisions. Factor scores are mixed: the short score ranks in the 20th percentile, EV/EBITDA sits at 10.2x, a modest compression over 30 days, and the EPS surprise rank of 19 confirms the company has struggled to beat estimates recently.
The institutional register is worth noting. BlackRock added nearly 954,000 shares in its latest filing to 9.8% of shares outstanding, making it the largest holder. Orbis Investment Management, a passive 13G filer, holds 11.3% but trimmed slightly from 11.5%. Spruce House Investment Management disclosed a fresh 5.2% position in July. No 13D activist is on the register. On the insider side, the only recent open-market activity was CEO Patrick Kelleher's exercise of options in August, followed by a small tax-withholding sale of around 4,600 shares. These are mechanical transactions and carry no directional signal.
Peer performance this week is broadly flat to modestly positive. UPS gained 1.8%, FDX was up 0.5% and EXPD added 1.7%. GXO's 0.2% weekly gain roughly matches the group. The stock has recovered about 1.4% over the past month after a difficult summer, but it remains well below the pre-August levels where most analyst targets were set.
The next earnings date is November 3. With short interest rising, options hedging elevated and a history of sharp post-earnings selloffs, the question heading into that print is whether the Goldman upgrade and the bullish consensus can hold if GXO again falls short of estimates.
See the live data behind this article on ORTEX.
Open GXO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
